Cargando…
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rapidly-emerging variants jeopardize antibody-based countermeasures against SARS-CoV-2. While recent cell culture experiments have demonstrated loss of potency of several anti-spike neutralizing antibodies against SARS-CoV-2 variant strains1-3, the in vivo significance of these results remains uncer...
Autores principales: | Diamond, Michael, Chen, Rita, Winkler, Emma, Case, James, Aziati, Ishmael, Bricker, Traci, Joshi, Astha, Darling, Tamarand, Ying, Baoling, Errico, John, Shrihari, Swathi, VanBlargan, Laura, Xie, Xuping, Gilchuk, Pavlo, Zost, Seth, Droit, Lindsay, Liu, Zhuoming, Stumpf, Spencer, Wang, David, Handley, Scott, Stine, W, Shi, Pei-Yong, Garcia-Knight, Miguel, Andino, Raul, Chiu, Charles, Ellebedy, Ali, Fremont, Daved, Whelan, Sean, Crowe, James, Purcell, Lisa, Corti, Davide, Boon, Andrianus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Journal Experts
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132254/ https://www.ncbi.nlm.nih.gov/pubmed/34013259 http://dx.doi.org/10.21203/rs.3.rs-448370/v1 |
Ejemplares similares
-
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope
por: VanBlargan, Laura A., et al.
Publicado: (2021) -
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021) -
SARS-CoV-2 variants show resistance to neutralization by many monoclonal and serum-derived polyclonal antibodies
por: Diamond, Michael, et al.
Publicado: (2021) -
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura A., et al.
Publicado: (2022) -
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
por: Darling, Tamarand L., et al.
Publicado: (2022)